Krystal Biotech IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 366.85 USD | 382,535 USD | 130,5 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 376,75 USD | 8 | 2 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 29.479.756 | 19,47 | 8,83 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Krystal Biotech Inc
Mitarbeiter 295
Handelsplatz NASDAQ
Ticker Symbol KRYS
IPO Datum 2017-09-20
Adresse 2100 Wharton Street, Pittsburgh, PA, United States, 15203
Webseite https://www.krystalbio.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Krish S. Krishnan M.B.A., M.S. | Founder, Chairman, President & CEO |
| 2 | Ms. Suma M. Krishnan | Founder, President of R&D and Director |
| 3 | Ms. Kathryn A. Romano CPA | Executive VP & Chief Accounting Officer |
| 4 | Mr. John C. Thomas | EVP, General Counsel & Corporate Secretary |
| 5 | Mr. John Karakkal | Vice President of North American Sales & Marketing |
| 6 | Dr. Stephane Paquette Ph.D. | Senior Vice President of Corporate Development |
| 7 | Mr. Josh Suskin | Senior Director & Head of US Human Resources |
| 8 | Mr. Laurent Goux | Executive VP & Head of International |
| 9 | Dr. David Chien M.D. | Senior Vice President of Clinical Development |
| 10 | Ms. Christine Wilson | Senior VP & Head of US Commercial |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | venBio Select Advisor LLC | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 5 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 6 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Soleus Capital Management, L.P. | 0,00% | 0,00 Mio. USD |
| 9 | Capital World Investors | 0,00% | 0,00 Mio. USD |
| 10 | Redmile Group, LLC | 0,00% | 0,00 Mio. USD |
| 11 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 12 | Hood River Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 13 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |
| 14 | Bellevue Group AG | 0,00% | 0,00 Mio. USD |
| 15 | Frazier Life Sciences Management, L.P. | 0,00% | 0,00 Mio. USD |
| 16 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 17 | William Blair Investment Management, LLC | 0,00% | 0,00 Mio. USD |
| 18 | First Trust Advisors L.P. | 0,00% | 0,00 Mio. USD |
| 19 | NORGES BANK | 0,00% | 0,00 Mio. USD |
| 20 | HHG PLC | 0,00% | 0,00 Mio. USD |